The Yorl business said it is now signing multiple new contracts with global market-leading pharmaceutical companies ...

UP Diliman biologists create an aptamer-based test for trichomoniasis detection, offering a potentially faster and more ...

York-based biotech firm, the Aptamer Group, has reported “revenue growth, solid cash position and strong technical progress” in its ...

Aptamer Group, a developer of novel Optimer ® binders to enable innovation in the life sciences sector, says it is gaining ...

So far, one aptamer drug that binds to vascular endothelial growth factor has been approved for age-related macular degeneration. However, aptamers are also being developed as anticoagulants and ...

York-based biotech firm, the Aptamer Group, has reported “revenue growth, solid cash position and strong technical progress” ...

(Image: Wikimedia Commons, CC BY 4.0) Aptamers can be used as therapeutic agents, targeting specific disease-related molecules or pathways. For example, the FDA-approved aptamer drug Pegaptanib ...

College of Science have developed an alternative and more cost-effective rapid test for the detection of a common type of ...

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private ...

Researchers at the University of the Philippines-Diliman (UPD) and international collaborators have developed a new detection ...

When metabolite binds (+M), the switching sequence is incorporated into the aptamer domain, and the expression platform folds into a terminator stem-loop (T), causing transcription to abort.